Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-i... by Muro, Kei, Dr, Boku, Narikazu, MD, Shimada, Yasuhiro, MD, Tsuji, Akihito, MD, Sameshima, Shinichi, MD, Baba, Hideo, Prof, Satoh, Taroh, MD, Denda, Tadamichi, MD, Ina, Kenji, MD, Nishina, Tomohiro, MD, Yamaguchi, Kensei, MD, Takiuchi, Hiroya, Prof, Esaki, Taito, MD, Tokunaga, Shinya, MD, Kuwano, Hiroyuki, Prof, Komatsu, Yoshito, MD, Watanabe, Masahiko, Prof, Hyodo, Ichinosuke, Prof, Morita, Satoshi, Prof, Sugihara, Kenichi, Prof

Get full text

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study by Boku, Narikazu, Dr, Yamamoto, Seiichiro, PhD, Fukuda, Haruhiko, MD, Shirao, Kuniaki, Prof, Doi, Toshihiko, MD, Sawaki, Akira, MD, Koizumi, Wasaburo, MD, Saito, Hiroshi, MD, Yamaguchi, Kensei, MD, Takiuchi, Hiroya, MD, Nasu, Junichiro, MD, Ohtsu, Atsushi, MD

Get full text

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial by Grothey, Axel, MD, Cutsem, Eric Van, Prof, Sobrero, Alberto, MD, Siena, Salvatore, MD, Falcone, Alfredo, MD, Ychou, Marc, MD, Humblet, Yves, MD, Bouché, Olivier, MD, Mineur, Laurent, MD, Barone, Carlo, MD, Adenis, Antoine, MD, Tabernero, Josep, MD, Yoshino, Takayuki, MD, Lenz, Heinz-Josef, MD, Goldberg, Richard M, MD, Sargent, Daniel J, PhD, Cihon, Frank, MS, Cupit, Lisa, MD, Wagner, Andrea, MD, Laurent, Dirk, DrMed

Get full text